Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.

The actions of recombinant human insulin-like growth factor-I (rhIGF-I) and insulin were compared in 21 healthy young (24 +/- 1 yr) and 14 healthy middle-aged (48 +/- 2 yr) subjects during 3-h paired euglycemic clamp studies using one of three doses (rhIGF-I 0.2, 0.4, and 0.8 micrograms/kg.min and i...

Cijeli opis

Bibliografski detalji

Izdano u:	J Clin Invest
Glavni autori:	Boulware, S D, Tamborlane, W V, Rennert, N J, Gesundheit, N, Sherwin, R S
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Clinical Investigation 1994
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294058/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8132753/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117065
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!